TrialJournal of Alzheimer's disease : JAD2019

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.

Martin R Farlow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.